A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study

PURPOSE: Recurrence risk management of patients with small (≤ 2 cm), node-negative, human epidermal growth factor receptor 2 (HER2)-positive breast cancer remains challenging. We studied the effects of adjuvant chemotherapy and/or trastuzumab and survival outcomes among these patients, using data fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubo, Makoto, Kawai, Masaaki, Kumamaru, Hiraku, Miyata, Hiroaki, Tamura, Kenji, Yoshida, Masayuki, Ogo, Etsuyo, Nagahashi, Masayuki, Asaga, Sota, Kojima, Yasuyuki, Kadoya, Takayuki, Aogi, Kenjiro, Niikura, Naoki, Miyashita, Minoru, Iijima, Kotaro, Hayashi, Naoki, Yamamoto, Yutaka, Imoto, Shigeru, Jinno, Hiromitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817748/
https://www.ncbi.nlm.nih.gov/pubmed/31451979
http://dx.doi.org/10.1007/s10549-019-05413-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817748/
https://www.ncbi.nlm.nih.gov/pubmed/31451979
http://dx.doi.org/10.1007/s10549-019-05413-7

Ejemplares similares